Safety and Efficacy of K-134 for the Treatment of Intermittent Claudication
Public ClinicalTrials.gov record NCT00783081. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the safety and efficacy of K-134 for the treatment of intermittent claudication.
Study identification
- NCT ID
- NCT00783081
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 387 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2008 (Type not available)
- Primary completion
- Jul 2010 (Actual)
- Completion
- Jul 2010 (Actual)
- Last update posted
- Mar 22, 2012
2008 – 2010
United States locations
- U.S. sites
- 30
- U.S. states
- 16
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Tucson | Arizona | — | — |
| Not listed | Little Rock | Arkansas | — | — |
| Not listed | Beverly Hills | California | — | — |
| Not listed | Los Angeles | California | — | — |
| Not listed | Sacramento | California | — | — |
| Not listed | Santa Rosa | California | — | — |
| Not listed | Vista | California | — | — |
| Not listed | Aurora | Colorado | — | — |
| Not listed | Clearwater | Florida | — | — |
| Not listed | Gulf Breeze | Florida | — | — |
| Not listed | Hialeah | Florida | — | — |
| Not listed | Jacksonville | Florida | — | — |
| Not listed | Pensacola | Florida | — | — |
| Not listed | Sarasota | Florida | — | — |
| Not listed | St. Petersburg | Florida | — | — |
| Not listed | Aurora | Illinois | — | — |
| Not listed | Chicago | Illinois | — | — |
| Not listed | Hinsdale | Illinois | — | — |
| Not listed | Indianapolis | Indiana | — | — |
| Not listed | Auburn | Maine | — | — |
| Not listed | St Louis | Missouri | — | — |
| Not listed | Oklahoma City | Oklahoma | — | — |
| Not listed | Danville | Pennsylvania | — | — |
| Not listed | Warwick | Rhode Island | — | — |
| Not listed | Charleston | South Carolina | — | — |
| Not listed | Amarillo | Texas | — | — |
| Not listed | Houston | Texas | — | — |
| Not listed | Norfolk | Virginia | — | — |
| Not listed | Richmond | Virginia | — | — |
| Not listed | Madison | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00783081, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 22, 2012 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00783081 live on ClinicalTrials.gov.